1. Home
  2. SY vs VYGR Comparison

SY vs VYGR Comparison

Compare SY & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$2.16

Market Cap

192.7M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.27

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
VYGR
Founded
2013
2013
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.7M
203.6M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
SY
VYGR
Price
$2.16
$3.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.50
$16.50
AVG Volume (30 Days)
205.3K
617.9K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
0.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$38.64
$34.04
Revenue Next Year
$30.63
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.28
$2.94
52 Week High
$5.35
$5.55

Technical Indicators

Market Signals
Indicator
SY
VYGR
Relative Strength Index (RSI) 64.48 45.16
Support Level $1.68 $2.96
Resistance Level $2.15 $3.28
Average True Range (ATR) 0.16 0.15
MACD 0.03 0.02
Stochastic Oscillator 80.46 56.52

Price Performance

Historical Comparison
SY
VYGR

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an aesthetic treatment platform in China connecting consumers with online services and offline treatments. Its online platform operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website, where both consumers and aesthetic practitioners can access media content, an engaging social community and a transparent reservation system. The company has four reportable segments: Aesthetic treatment services group, Platform service group, Wuhan Miracle, and Others. The majority of revenue is derived from the Platform service group, which generates revenue by providing information services and reservation services. All the company's revenues are derived from within the PRC.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: